No Data
No Data
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Palisade Bio Selected For Poster Presentation At The 2025 Crohn's & Colitis Congress February 6-8, 2025
Palisade Bio Completes All Five SAD Cohorts, Advanced MAD Cohorts for PALI-2108
Express News | Palisade Bio Completes All Five Sad Cohorts and Advances to Mad Cohorts of Phase 1a/B Study of Pali-2108 for Treatment of Ulcerative Colitis
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)